Editas Medicine, Inc. (EDIT) CEO Cindy Collins on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha]
Editas Medicine, Inc. (EDIT)
Last editas medicine, inc. earnings: 2/26 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.editasmedicine.com
Company Research
Source: Seeking Alpha
Editas Medicine, Inc. (EDIT) CEO Cindy Collins on Q1 2019 Results - Earnings Call Transcript Editas Medicine, Inc. (NASDAQ: EDIT Company Participants Mark Mullikin - VP, Finance and IR Cindy Collins - Interim CEO Eric Ek - Interim CFO Charlie Albright - Chief Scientific Officer Conference Call Participants Amanda Murphy - William Blair Steve Seedhouse - Raymond James Phil Nadeau - Cowen & Company Xiaobin Gao - Barclays Peter Lawson - SunTrust Robinson Humphrey Whitney Ijem - Guggenheim Securities Operator Good afternoon, and welcome to Editas Medicine’s First Quarter 2019 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the Company’s request. I would now like to turn the call over to Mark Mullikin, Vice President of Finance and Investor Relations at Editas Medicine. Thank you, operator. Good afternoon, everyone, and welcome to our first quarter 2019
Show less
Read more
Impact Snapshot
Event Time:
EDIT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDIT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDIT alerts
High impacting Editas Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
EDIT
News
- Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update [Yahoo! Finance]Yahoo! Finance
- 1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right. [Yahoo! Finance]Yahoo! Finance
- Insider Sells Shares of Editas Medicine Inc (EDIT) [Yahoo! Finance]Yahoo! Finance
- 1 Beaten-Down Stock With 55% Upside, According to Wall Street [Yahoo! Finance]Yahoo! Finance
- Why Editas Medicine Stock Soared as Much as 42% Higher This Week [Yahoo! Finance]Yahoo! Finance
EDIT
Earnings
- 2/28/24 - Beat
EDIT
Sec Filings
- 3/5/24 - Form 4
- 3/5/24 - Form 4
- 3/5/24 - Form 4
- EDIT's page on the SEC website